• Phare
  • Validé par KD/KO

Anticorps Recombinant de lapin anti-NRF2, NFE2L2

NRF2, NFE2L2 Recombinant Antibody for WB, IHC, IF/ICC, FC (Intra), IP, Indirect ELISA, ChIP-qPCR

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, IHC, IF/ICC, FC (Intra), IP, Indirect ELISA, ChIP-qPCR

Conjugaison

Non conjugué

CloneNo.

1I21

N° de cat : 80593-1-PBS

Synonymes

NFE2L2, NRF2, HEBP1, NF-E2-related factor 2, NFE2-related factor 2



Informations sur le produit

80593-1-PBS cible NRF2, NFE2L2 dans les applications de WB, IHC, IF/ICC, FC (Intra), IP, Indirect ELISA, ChIP-qPCR et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène NRF2, NFE2L2 Protéine recombinante Ag9489
Nom complet nuclear factor (erythroid-derived 2)-like 2
Masse moléculaire calculée 605 aa, 68 kDa
Poids moléculaire observé 110 kDa, 68 kDa
Numéro d’acquisition GenBankBC011558
Symbole du gène NRF2
Identification du gène (NCBI) 4780
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

NRF2, also named as NFE2L2, belongs to the bZIP family and CNC subfamily. It is a transcription activator that binds to antioxidant response (ARE) elements in the promoter regions of target genes. NRF2 is important for the coordinated up-regulation of genes in response to oxidative stress. It may be involved in the transcriptional activation of genes of the beta-globin cluster by mediating enhancer activity of hypersensitive site 2 of the beta-globin locus control region. Nrf2 is a key player in the regulation of genes encoding for many antioxidative response enzymes.The expression of NRF2 may be induced under oxidative stress (PMID:14567983).In lung cancer, Nrf2 activation in malignant cells has been associated with tumor progression and chemotherapy resistance(PMID:20534738). Identifying patients with abnormal NRF2 expression may be important for selection for chemotherapy in NSCLC. As new investigators break into the emerging field of Nrf2 research, confusion regarding the correct migratory pattern of Nrf2 is causing doubts about the accuracy and reproducibility of published results. This letter provides solid evidence that the actually observed molecular weight of Nrf2 is about 70kDa and 95-110 kDa. (PMID: 22703241).

{{ptg:RelatedPrimaryAntibodies}}